loading...

Brief Assessment of Cognition in Schizophrenia (BACS)

Keefe RS; Goldberg TE; Harvey PD; Gold JM; Poe M; Coughenour L

ProQolid

Basic description

  • Published in 2004
Authors

Keefe RS; Goldberg TE; Harvey PD; Gold JM; Poe M; Coughenour L

Copyright
BACS © Duke University. All rights reserved.
Duke University retains the copyright for all translations of the BACS
Objective
To assess the aspects of cognition found to be the most impaired and most strongly correlated with outcomes in patients with schizophrenia, especially in clinical trials of cognitive enhancement
Therapeutic area
  • Mental Disorders
Therapeutic indication

Schizophrenia

Type of Clinical Outcome Assessment (COA)
  • perfo PerfO
Original language(s)
  • English for the USA
Translations
8 translation(s)
Bibliographic reference(s) of the original questionnaire

Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004 Jun 1;68(2-3):283-97 (PubMed abstract)

Atkins AS, Tseng T, Vaughan A, Twamley EW, Harvey P, Patterson T, Narasimhan, M, Keefe RS. Validation of the tablet-administered Brief Assessment of Cognition (BAC App). Schizophr Res. 2017 Mar;181:100-106 (Full text article)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us